Results 21 to 30 of about 17,151,553 (293)

Concentrations of Fecal Bile Acids in Participants with Functional Gut Disorders and Healthy Controls

open access: yesMetabolites, 2021
Bile acids are metabolites involved in nutrient absorption and signaling with levels influenced by dietary intake, metabolic processes, and the gut microbiome.
Shanalee C. James   +9 more
doaj   +1 more source

Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D

open access: yes, 2022
Fecal microbiota transplantation (FMT) is an attractive strategy to correct microbial dysbiosis in diarrhea-predominant irritable bowel syndrome (IBS-D).
John M. Kelley   +17 more
core   +1 more source

Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations

open access: yesCells, 2022
Irritable bowel syndrome (IBS) is a disorder of brain-gut interaction characterised by abdominal pain and changes in bowel habits. In the diarrhoea subtype (IBS-D), altered epithelial barrier and mucosal immune activation are associated with clinical ...
Cristina Pardo-Camacho   +19 more
doaj   +1 more source

Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea

open access: yesFrontiers in Pharmacology, 2021
Irritable bowel syndrome (IBS) is one of the most common disorders of the gut-brain axis, which affects approximately 4% of the global population. The Rome IV criteria define IBS as chronic or recurrent abdominal pain associated with altered bowel habits.
Esther Colomier   +5 more
doaj   +1 more source

Association of Fecal Microbiota with Irritable Bowel Syndrome-Diarrhea and Effect of Traditional Chinese Medicine for Its Management

open access: yesGastroenterology Research and Practice, 2021
Changes in intestinal microbiota have been linked to the development of diarrhea predominant irritable bowel syndrome (IBS-D). In order to better elucidate the relationship between intestinal microbiota changes and IBS-D, we compared fecal microbiota of ...
Fang Yang   +6 more
doaj   +1 more source

Efficacy of diet restriction with or without probiotic for treatment of patients with IBS-D: Phase I-II clinical trial. [PDF]

open access: yesImmun Inflamm Dis, 2023
Background and Aim Diet is a major contributor to irritable bowel syndrome (IBS) and is also a powerful tool for treatment of IBS. This study compared two diets and explored the effectiveness of the diets when combined with a probiotic for treatment of ...
Zhao XS   +7 more
europepmc   +2 more sources

Evaluation of prakṛti and quality-of-life in patients with irritable bowel syndrome

open access: yesAncient Science of Life, 2015
Objective: To evaluate the prakṛti of irritable bowel syndrome (IBS) patients and its association with IBS subtypes and quality-of-life (QOL). Methodology: IBS patients with the consistent subtype in the last 6 months were recruited.
Sudatta G Shirolkar   +2 more
doaj   +1 more source

Tong-Xie-Yao-Fang Regulates 5-HT Level in Diarrhea Predominant Irritable Bowel Syndrome Through Gut Microbiota Modulation

open access: yesFrontiers in Pharmacology, 2018
Tong-Xie-Yao-Fang (TXYF) has been widely used for the treatment of diarrhea-predominant irritable bowel syndrome (IBS-D) in traditional Chinese medicine. However, its mechanism of action in the treatment of IBS-D remains to be fully understood.
Junchen Li   +9 more
doaj   +1 more source

Golden bifid might improve diarrhea-predominant irritable bowel syndrome via microbiota modulation

open access: yesJournal of Health, Population and Nutrition, 2022
Objective Gut microbiota might play a crucial role in the pathogenesis of irritable bowel syndrome (IBS), and probiotics supplement may be an effective treatment option.
Mei Luo   +3 more
doaj   +1 more source

The Value of PHQ-9 and GAD-7 for Screening Emotional Disorders in IBS-D and the Specificity of the Gut Flora Associated with Emotional Comorbidity: Preliminary Findings. [PDF]

open access: yesNeuropsychiatr Dis Treat
Jun Zhao,1,2,* Xia Li,3,* Xin Wang,4 Xuefei Wang,4 Xin Hao,2 Zhigang Li,2 Lin Zhu1 1Department of Integrated Traditional and Western Medicine, West China Hospital, Sichuan University, Chengdu, 610044, People’s Republic of China; 2School of ...
Zhao J   +6 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy